cerrar
Tagged with R&D

Markus Sieger – CEO, Polpharma
Markus Sieger, CEO of Polpharma, outlines his global strategy for the company, focused on OTC and CHC, internationalization and a strong R&D…

Interview: Gaby Murphy – Managing Director, EMD Serono,…
At the 350th anniversary of the company, Gaby Murphy, EMD Serono’s managing director, gives an insight into the turning point for the affiliate in…

Lithuania’s Biotech Potential
Lithuania’s biotech sector has grown by between 20 and 25 percent over the last five years and accounts for over one percent of the entire…

Interview: Santiago Salguero – Executive Director,…
Santiago Salguero, executive director of the Association of Latin American Pharmaceutical Laboratories in Ecuador (ALAFAR), elaborates on the…

Interview: Pierre Gabriel Côté – CEO, Investissement…
Investissement Québec (IQ) contributed to the completion of 65 international projects in 2017 and hosts Pfizer, Sanofi, and Merck amongst over 160 IT…

Interview: Ross Glover – General Manager, Taiho Pharma…
Taiho Pharmaceutical Co., Ltd. (TPC), Japan, part of Otsuka Holdings, established its Canadian affiliate in 2017. Ross Glover, general manager for…

Interview: Paulo Wickbold Marques – Head of Operations,…
Upon opening an R&D center in Mississauga in 2017, Biolab Pharma Canada, headed by Paulo Wickbold Marques, became the first Brazilian…

The UK Life Sciences Ecosystem: A Snapshot
Much of the new inward investment in the UK from international pharmaceutical companies is from those that wish their discovery science to be in…

Simon Gillespie – Chief Executive, British Heart Foundation…
Simon Gillespie of the British Heart Foundation (BHF), the UK’s leading national heart charity, outlines the organization’s mission, the issues…

Hilary Evans – Chief Executive, Alzheimer’s Research UK
Hilary Evans of Alzheimer’s Research UK (ARUK), the UK’s leading national research charity in the field of dementia, discusses her…

Interview: Vatché Bartekian – President, Vantage…
Introducing Vantage BioTrials, a CRO focused on operational excellence with a lean and holistic approach to each project, Vatché Bartekian, president…

Interview: Angel Guevara – Professor and Molecular…
Angel Guevara, molecular biologist and professor at the Central University of Ecuador (UCE), discusses Ecuador’s potential as a clinical trial…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here